Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Corvus Pharmaceuticals Inc (CRVS)
Corvus Pharmaceuticals Inc (CRVS) Financials

CRVS Corvus Pharmaceuticals Inc

5.08

0.38 (8.09%)

After Hours

Last Updated: 00:11:16

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-30.489	-47.388	-44.073	-46.238	-7.087	-44.353	-46.492	-47.506
Return on Equity (%)	-71.534	-51.152	-48.1	-51.444	-8.369	-51.079	-53.898	-57.024
Return on Invested Capital (%)	-74.041	-52.362	-50.786	-54.141	-83.713	-89.454	-87.983	-101.416
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	3.773	4.032	3.763	2.544	2.543	2.087	1.205	0.789
Earnings Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
Cash Per Share	0.143	2.144	1.337	0.184	0.58	1.363	0.283	0.257
Working Capital Per Share	3.696	3.91	3.702	2.473	1.17	1.324	0.707	0.43
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
EBITDA Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
Free Cash Flow Per Share	-0.988	-2.673	-1.617	-1.695	-0.231	-0.939	-0.889	-0.554

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	20.92M	21.04M	29.32M	27.95M	28.37M	46.55M	46.55M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	46.55M	46.55M	N/A	48.9M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	302.01M
Price to Earnings Ratio	-12.1
Price to Sales Ratio	0
Price to Cash Ratio	25.92
Price to Book Ratio	8.45
Dividend Yield	-

Share Statistics

Shares Outstanding	64.26M
Average Volume (1 week)	3.78M
Average Volume (1 Month)	1.48M
52 Week Change	236.42%
52 Week High	10.00
52 Week Low	1.30

More Ratios Coming Soon!

Corvus Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions